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Abstract
Background: We compared the performance of two new commercial tests for the detection of dengue NS1 protein during
the clinical phase of dengue virus (DENV) infection—an immunochromatographic test allowing rapid detection of the NS1
antigen, Dengue NS1 Ag STRIP (Bio-Rad Laboratories - Marnes La Coquette, France), and a two-step sandwich-format
microplate enzyme-linked immunosorbent assay (ELISA), pan-E Dengue Early ELISA (Panbio - Brisbane, Australia)—with a
one-step sandwich-format microplate ELISA, the Platelia Dengue NS1 Ag test (Bio-Rad).
Methods: We tested 272 serum samples from patients with dengue disease. Of these, 222 were from patients with acute
infection of one of the four dengue serotypes, detected by RT-PCR and/or virus isolation. Forty-eight acute-phase serum
samples from patients not infected with dengue virus were also included.
Results: The sensitivity of the Platelia Dengue NS1 Ag test on acute serum samples (n=222) was 87.4% (95% confidence
interval: 82.3% to 91.5%); that of Dengue NS1 Ag STRIP was 81.5% (95% CI: 75.8% to 86.4%) after 15 minutes and 82.4%
(95% CI: 76.8% to 87.2%) after 30 minutes. Both tests had a specificity of 100% (97.5% CI, one-sided test: 92.6% to 100.0%).
The pan-E Dengue Early ELISA had a sensitivity of 60.4% (95% CI: 53.4% to 66.8%) and a specificity of 97.9% (95% CI: 88.9%
to 99.9%).
Conclusion: Our findings support the use of diagnostic tools based on the NS1 antigen detection for the diagnosis of acute
DENV infection. The immunochromatographic test, Dengue NS1 Ag STRIP—the first rapid diagnostic test for DENV
infection—was highly sensitive and specific, and would therefore be a suitable first-line test in the field. The pan-E Dengue
Early ELISA was less sensitive than the Platelia test; this two-step ELISA should be combined with DENV IgM antibody
detection for the diagnosis of DENV infection.
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Introduction
Dengue virus (DENV) is a mosquito-borne virus (family
Flaviviridae, genus Flavivirus). Four viral serotypes of DENV
(DENV-1 to DENV-4) cause disease in humans. Symptoms range
from mild fever, the most common form, to potentially fatal
dengue hemorrhagic fever (DHF) and dengue shock syndrome
(DSS) or encephalitis and hepatitis. The disease is now endemic in
more than 100 countries in tropical areas, threatening over 2.5
billion people. It currently affects around 100 million people every
year [1]. Among affected individuals, 500,000 have DHF and
around 25,000, mostly children, die. According to World Health
Organization estimates, the incidence of dengue disease has
increased by a factor of 30 over the past 50 years [2]. Many of
these epidemiological changes can be attributed to the increase
and spread of the vector Stegomyia aegypti (formerly Aedes aegypti), an
urban mosquito, together with population growth, urbanization
and increases in human travel [3].
Flaviviruses are enveloped, single-stranded, positive-sense RNA
viruses. The genomic RNA is about 11 kb long and contains 10
genes encoding three structural proteins (capsid [C], envelope [E],
and membrane [M]), and seven nonstructural proteins (NS1,
NS2a, NS2b, NS3, NS4a, NS4b, and NS5) [4]. The polycistronic
coding region is flanked by non-coding regions at its 59 and 39
ends. The nonstructural protein, NS1, is a highly conserved
glycoprotein, but its biological activity has not been established.
During in vitro infection, the flavivirus NS1 protein is expressed as
an intracellular membrane-associated form essential for viral
replication [5,6] or as a cell surface-associated form that may be
involved in signal transduction [7]. In solution, secreted NS1
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sera of dengue virus-infected patients throughout the clinical phase
of the disease [8–10]. A recent study demonstrated that soluble
NS1 protein binds to endothelial cells and, following recognition
by anti-NS1 antibodies, could contribute to plasma leakage during
severe dengue virus infection [11].
The detection of secreted NS1 protein represents a new
approach to the diagnosis of acute dengue infection. A recently
developed commercially available diagnostic test based on dengue
NS1 antigen-capture ELISA (Platelia Dengue NS1 Ag test, Bio-
Rad Laboratories, Marnes la Coquette, France), was investigated
in two studies (one in South America and the other in Southeast
Asia); the test had an overall sensitivity of 88.7% and 93.4% in the
two studies, with 100% specificity [12,13].
We evaluated and compared the performance of the Platelia
Dengue NS1 Ag test from Bio-Rad Laboratories with two new
commercial tests for the detection of dengue virus NS1 antigen
(Ag) in patients with clinically diagnosed DENV infection: Dengue
NS1 Ag STRIP, an immunochromatographic assay developed by
Bio-Rad Laboratories, and pan-E Dengue Early ELISA, an
enzyme-linked immunosorbent assay developed by Panbio
(Brisbane, Australia).
Materials and Methods
Clinical samples
We used a panel of human serum samples from the collection of
the Centre National de Re ´fe ´rence des Arbovirus et virus Influenza (the
French National Reference Center (NRC) for Arboviruses and
Influenza viruses), Re ´gion Antilles-Guyane, based at the Institut Pasteur de
la Guyane. Sera were collected from patients previously diagnosed
with Dengue infection. No clinical investigation was conducted
and no personal identifiers were included; therefore, no IRB
approval was sought for this study. The laboratory as NRC
conducted the collection of serum samples with approval from the
French Ministry of Health. The database used by the NRC is
registered with the Commission Nationale de l’Informatique et des Liberte ´s
(CNIL). This database provided clinical information about the age
and sex of each patient, the date of serum collection and the day
on which symptoms occurred (onset of fever taken as day 0, i.e. first
24 hours). Clinical data and serum samples were collected from
patients presenting a dengue-like illness in the context of the
dengue surveillance activity of the NRC.
Dengue infection diagnosis
DENV was isolated by cell culture and the DENV genome was
detected by RT-PCR, as previously described, in acute-phase
serum samples [14,15]. Briefly, for virus isolation, acute-phase
serum samples from febrile patients were diluted 10-fold in
Leibowitz medium containing 3% fetal calf serum, and dilutions
were injected into subconfluent AP 61 cell cultures, as previously
described. After 7 days of culture, cells were harvested, and dengue
viruses were identified according to serotype by an indirect
immunofluorescence assay (IFA) with monoclonal antibodies
specific for DENV-1, -2, -3, and -4 viruses (provided by CDC,
Fort Collins, CO, USA). DENV was isolated from 104 samples,
and DENV RNA was detected in an additional 82 samples by RT-
PCR. A third set of 36 samples was positive for both virus isolation
and RT-PCR. Based on the epidemiological situation for dengue
in French Guiana, we considered patients with positive detection
of the genome associated with dengue-like syndrome to be
confirmed cases of dengue infection.
Acute- and early convalescence-phase serum samples were
tested for IgM antibodies against DENV, using the MAC-ELISA
test, as previously described [16]. All sera were tested for the
presence of DENV IgG antibody using a test adapted from a
previously described indirect ELISA [17]. Briefly, the wells of flat-
bottomed microplates (Polysorp, Nunc) were coated with 100 mlo f
dengue antigen diluted 1:2,000 in phosphate-buffered saline (PBS).
Normal mouse brain antigen was diluted in an identical manner
and used to coat other adjacent wells. After overnight incubation
at 4uC, the microplates were washed three times with PBS
containing 0.1% Tween 20 (PBS-T; both reagents from Sigma
Laboratories, l’Isle d’Abeau Chesnes, France). The sera were
diluted (1:100) in PBS containing 0.1% Tween 20 and 5% nonfat
dried milk (PBS-T-NDM) and added to each well (100 ml/well).
Six negative and two positive reference sera were included in each
plate as controls. The negative controls consisted of sera from
patients with other febrile illnesses but negative for dengue
infection. The plates were then incubated for 2 h at 37uC and
washed three times with PBS-T. Bound IgG was detected by
adding 100 ml of horseradish peroxidase-conjugated goat anti-
human IgG (Jackson Immunoresearch Laboratories, West Grove,
PA, USA) diluted 1:2,000 in PBS-T-NDM to each well. The plates
were incubated for 1 h at 37uC and washed with PBS-T. Bound
antibodies were visualized by adding 100 ml of tetramethylbenzi-
dine (Sigma Laboratories) to each well. After incubation for
15 min at room temperature, absorbance at 650 nm (A650) was
read with a microplate reader, and the DA650 was calculated
(DA650=DA650 Den Ag2DA650 control Ag). For validation of the
test, the DA650 of the positive control serum had to be $0.5 and
the DA650 of the negative control serum had to be #0.2. The mean
(6the standard deviation) DA650 values for the negative controls
were then determined. A result was considered negative if DA650
was less than the mean value for the negative control plus two
standard deviations, indeterminate when DA650 was between two
and three standard deviations, and positive when DA650 values was
more than three standard deviations greater than the mean of the
negative control.
We studied a panel of 320 sera previously tested for NS1 antigen
with the Platelia Dengue NS1 Ag kit [12]. Two hundred seventy-
two DENV-infected sera were characterized as follows: (i) DENV-
Author Summary
Dengue is a viral disease transmitted by mosquitoes that is
endemic in more than 100 countries in tropical areas,
threatening over 2.5 billion people. It causes a wide range
of symptoms and has severe forms. In reference labora-
tories, dengue disease is confirmed by virus isolation or
genome detection during the acute phase, and by
serological methods during the early convalescent phase.
The viral NS1 protein circulates in the sera of infected
patients throughout the clinical phase of the disease.
Novel diagnostic tests based on NS1 detection have been
recently developed and marketed. We compared the
performance of two tests for detecting dengue NS1
protein during the clinical phase of dengue infection (an
immunochromatographic test (ICT) from Bio-Rad allowing
rapid detection of the NS1 antigen and a two-step
sandwich-format ELISA from Panbio) with the one-step
sandwich-format microplate ELISA (Bio-Rad). The ICT test
performed better than the ELISA test from Panbio. This
study confirms that diagnostic tests based on NS1 could
be used in routine clinical practice in poorly equipped
laboratories and that dengue diagnosis could therefore be
confirmed without the need for testing in reference
laboratories. This represents a crucial step towards the
control of dengue disease in the human population.
Dengue NS1 Ag Detection Using ICT and ELISA Tests
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(n=46) acute sera (n=222 in total), (ii) 50 non serotyped serum
samples containing DENV IgM antibody detected during different
dengue outbreaks from French Guiana (Table 1). We also
included 48 additional acute-phase serum samples (days one to
four) from patients presenting dengue-like syndrome (temperature
of $38.5uC, arthralgia, headache and/or myalgia), for whom
recent dengue infection was ruled out based on acute and
convalescent sera. Of the 222 acute serum samples with dengue
virus detected by RT-PCR and/or virus isolation, 194 (87.4%;
95% CI: 82.3% to 91.5%) were positive for the Platelia Dengue
NS1 Ag test; four sera (1.8%) with equivocal results were
considered negative based on further statistical analysis. We used
these well-characterized sera to compare the performance of
Dengue NS1 Ag STRIP and pan-E Dengue Early ELISA with the
Platelia Dengue NS1 Ag test.
Based on the WHO criteria for case definitions of dengue fever,
DHF and DSS, all serum samples tested were collected from
patients with clinical symptoms of classical dengue fever (fever,
headache, myalgia, and arthralgia) with or without a rash or minor
hemorrhagic manifestations. No patient presented severe clinical
symptoms of DHF or DSS [18].
New commercial tests based on dengue NS1 antigen
detection
Dengue NS1 Ag STRIP (Bio-Rad Laboratories) is an
immunochromatographic test (ICT) for the rapid detection of
NS1 antigen. Briefly, one drop of migration buffer was added to
50 mL serum in a specimen tube and a strip was placed in the tube.
The strip has two lines: a control line (C) (‘‘biotin – gold colloidal
particles coated with streptavidin’’ complex) and a test line (T)
(‘‘monoclonal anti-NS1 antibodies (mAb) – NS1 Ag – gold
colloidal particles coated with anti-NS1 mAb’’ complex). The
appearance of the T and C lines after a migration time of
15 minutes (min) indicates a positive result. The appearance of the
C line alone indicates a negative result. If the C line is not present,
the test is considered invalid and is repeated. It is recommended
that strips giving ambiguous (faint color at the T line) or negative
results are put back in the tube after the initial reading and left for
a further 15 min for re-evaluation. We evaluated all samples at
15 min (ICT 15 min) and then at 30 min (ICT 30 min).
The pan-E Dengue Early ELISA (Panbio) is a two-step
sandwich-format microplate enzyme-linked immunosorbent assay
for the detection of NS1 antigen. The test uses polyclonal and
monoclonal antibodies for capture and detection, respectively.
Panel serum samples and control serum samples provided in the
kit were diluted 1:10 (135 mL of serum diluents and 15 mL of each
serum sample and control sample). Diluted serum and control
samples (100 mL) were placed in microplate wells coated with anti-
NS1 polyclonal antibodies. The microplate was incubated for one
hour at 37uC, and then washed six times. Horseradish peroxidase-
conjugated anti-NS1 Mab (100 mL) was added to each well and
the microplate was incubated for one hour at 37uC, then washed
six times. Immune complexes were detected using a color
development reaction (100 mL of tetramethylbenzidine added to
each well). The plate was incubated for 10 minutes room
temperature, and the enzymatic reaction was then stopped with
phosphoric acid. Absorbance at 450/620 nm was determined
within 30 minutes.
We used the average absorbance of triplicate readings from the
calibrator, multiplied by the calibration factor (provided in the kit),
to calculate the cut-off value (CO). An index value was calculated
by dividing the sample absorbance by the CO. Panbio Units were
calculated by multiplying the index value by ten. According to the
manufacturer’s recommendations, samples with index values less
than 0.9 were considered negative (no detectable dengue NS1 Ag);
those with index values between 0.9 and 1.1 were equivocal for the
presence of dengue NS1 Ag, and samples with index values greater
than 1.1 were considered positive (presence of detectable dengue
NS1 Ag).
The technicians carrying out Dengue NS1 Ag STRIP and pan-
E Dengue Early ELISA were blind to the DENV-infection status
of the panel of serum samples. For each strip, two people read the
results independently. When discordance was observed between
Platelia and ICT and/or pan-E results, the discordant serum was
retested with all three tests to avoid discrepancies due to the effects
of serum sample storage.
Statistical analysis was performed with STATA version 9.0
(STATA Corporation, College Station, TX, USA).
Results
The sensitivity of each of the three NS1 antigen detection tests
with the 272 DENV-infected sera is detailed in Table 2. All sera
testing positive for the presence of NS1 with the pan-E Dengue
Early ELISA also tested positive with the Dengue NS1 Ag STRIP
Table 1. Description of the panel with the DENV-infected serum samples (n=272) used for evaluating the sensitivity of the Platelia
Dengue NS1 Ag test, Dengue NS1 Ag STRIP and pan-E Dengue Early ELISA, according to the number of days after onset of fever.
Days after onset of
fever Acute phase (n=222) Early convalescence phase (n=50)
DENV-1 DENV-2 DENV-3 DENV-4 IgM
0 54920
11 02 12 71 60
2 973 6 80
37 8 1 41 12
4 021 2 82
5 20211 3
6 00101 4
$7 00001 9
Total 33 42 101 46 50
doi:10.1371/journal.pntd.0000280.t001
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positive for NS1 with the Dengue NS1 Ag STRIP also tested
positive with the Platelia Dengue NS1 Ag test (Table 2). Using the
Dengue NS1 Ag STRIP, 207 (76.1%; 95% CI: 70.6% to 81.0%)
samples gave positive results at 15 minutes and 211 (77.6%; 95%
CI: 72.1% to 82.4%) samples gave positive results at 30 minutes.
One serum sample, collected on day four, gave ambiguous results
at 15 minutes (faint Dengue NS1 Ag STRIP T line), and a positive
result after 30 minutes (positive with the Platelia test, with a ratio
greater than 5.0). A second serum sample, collected on day 0, was
considered negative after 15 minutes and positive after 30 minutes
(positive with the Platelia test, with a ratio of 3.9). With the pan-E
Dengue Early ELISA, 150 serum samples (55.1%; 95% CI: 49.0%
to 61.2%) tested positive. Nine other serum samples collected on
day 1 (n=1), day 2 (n=2), day 3 (n=2), day 4 (n=2) and day 6
(n=2) were considered equivocal with the pan-E Dengue Early
ELISA, whereas these samples had ratios of 2.8 (n=1) or greater
than 5.0 (n=8) with the Platelia test.
Table 3 details the sensitivities of the three NS1 tests and of the
MAC-ELISA according to the number of days after onset of fever.
The sensitivity of ICT at 30 minutes was 94.2%, using the Platelia
Dengue NS1 Ag test as a reference (100%), whereas that of the
pan-E Dengue Early ELISA was 66.9%. The sensitivity of pan-E
Dengue Early ELISA for DENV diagnosis between days 0 and 4
(60.0%) increased significantly, to 64.0%, when combined with
IgM detection (McNemar’s test: 9.0 p=0.003) (Data not shown).
Table 4 compares the sensitivity of the Dengue NS1 Ag STRIP
and pan-E Dengue Early ELISA tests with that of the Platelia
Dengue NS1 Ag test, as a function of DENV serotype. No
significant difference was observed between the four DENV
serotypes for sensitivity of the Platelia test (x
2=0.49, P=0.92), the
ICT at 15 min (x
2=0.05, P=0.99) or the ICT at 30 min
(x
2=0.25, P=0.97). However, a significantly lower sensitivity
(21.7%; 95% CI: 10.9% to 36.4%) for DENV-4 serum samples
was observed with the Panbio test (x
2=40.1, P,0.0001).
The sensitivity of Platelia Dengue NS1 Ag, ICT at 15 min and
30 min, and pan-E Dengue Early ELISA tests for acute sera with
positive RT-PCR or viral culture results is presented in Table 5.
No significant difference was observed between the sensitivity (Se)
of ICT 15 min (Se=81.8%; 180/220), ICT 30 min (Se=82.7%;
182/220) and Platelia Dengue NS1 Ag (Se=87.7%; 193/220)
(x
2=3.3, P=0.19) for acute serum samples collected between days
0 and 4 after fever onset. However, a significant difference in
sensitivity was observed between pan-E Dengue Early ELISA
(Se=60.0%; 132/220) and Platelia Dengue NS1 Ag (x
2=43.8,
P,0.0001), ICT 15 min (x
2=25.4, P,0.0001) and ICT 30 min
(x
2=27.8, P,0.0001).
There was a significant difference in the sensitivity of NS1
detection tests between serum samples with positive and negative
results for DENV IgG detection (Platelia: x
2=24.5, P,0.0001;
ICT 15 min. x
2=37.2, P,0.0001; ICT 30 min. x
2=33.3,
P,0.0001; Pan-E: x
2=27.0, P,0.0001) (Table 6). This difference
was observed regardless of the timing of serum sample collection
(Figures 1A & 1B). Furthermore, we observed an increase in the
sensitivity of the three NS1 detection tests between sera collected
at day 0 and those collected on day 3, with the largest increase
observed with the pan-E Dengue Early ELISA (Figure 1B).
The specificity testing was conducted with the 48 acute-phase
serum samples from dengue-negative patients. The Platelia
Dengue NS1 Ag test, ICT 15 min and 30 min had a specificity
of 100% (48/48; 97.5% CI: 92.6% to 100%, one-sided test),
whereas the specificity of the pan-E Dengue Early ELISA was
97.9% (47/48; 95% CI: 88.9% to 99.9%). For one patient, we
considered the positive Panbio test for the acute-phase serum
sample to be a false positive result because virus isolation, genome
and IgM detection tests were all negative. Moreover, for the 48
non-DENV-infected patients, all acute-phase and early convales-
cent sera were tested for IgM directed against two other
flaviviruses (Saint-Louis encephalitis and yellow fever antigen,
data not shown), and for the false-positive Panbio result, the paired
sera were retested to confirm the absence of cross-reactivity with
these two flaviviruses.
Discussion
We compared three diagnostic tests for early detection of the
NS1 antigen secreted in the plasma of patients with dengue
infection during the acute phase of the disease. The Platelia
Table 2. NS1 Ag detection using Platelia Dengue NS1 Ag test, Dengue NS1 Ag STRIP and pan-E Dengue Early ELISA in patients
with DENV-infection (n=272) and among acute-phase serum samples from dengue-negative patients (n=48).
Platelia Dengue NS1 Ag test Dengue NS1 Ag STRIP 30 min. Dengue NS1 Ag STRIP 15 min. pan-E Dengue Early ELISA
Positive 207 Positive 149
Positive 211 Negative 58
Negative 4 Positive 0
Positive 224 Negative 4
Positive 0 Positive 0
Negative 13 Negative 0
Negative 13 Positive 1
Negative 12
Negative 48 Negative 48 Negative 48 Negative 48
Se=82.4% (224/272) [77.3–86.7]
a Se=77.6% (211/272) [72.1–82.4]
a Se=76.1% (207/272) [70.6–81.0]
a Se=55.1% (150/272) [49.0–61.2]
a
Negative 48 Negative 48 Negative 48 Negative 47
Sp=100% (48/48) [92.6–100]
b Sp=100% (48/48) [92.6–100]
b Sp=100% (48/48) [92.6–100]
b Sp=97.9% (47/48) [88.9–99.9]
c
aSe: Sensitivity (%), number of NS1 positive test among patients with confirmed DENV infection (n=272) – [95% CI].
bSp: Specificity (%), NS1 negative test among acute-phase serum samples from dengue-negative patients (n=48) – [97,5% CI, one-sided test)].
cSp: Specificity (%), NS1 negative test among acute-phase serum samples from dengue-negative patients (n=48) – [95% CI].
doi:10.1371/journal.pntd.0000280.t002
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www.plosntds.org 6 August 2008 | Volume 2 | Issue 8 | e280Dengue NS1 Ag test has been already demonstrated to be effective
for NS1 detection [12–13]. We show here a high rate of detection
in samples from patients with the rapid immunochromatographic
test, Dengue NS1 Ag STRIP — the first ICT test developed for
NS1 detection — for all four DENV serotypes. This rapid
diagnostic test (RDT) is convenient, easy to use, and the results are
obtained in 15 minutes, or 30 minutes for ambiguous results. The
RDT does not involve any specific laboratory equipment, except a
microcentrifuge for serum separation. This test can detect NS1 Ag
from serum samples, but not from whole blood. The development
of an ICT for the NS1 detection in whole blood would allow rapid
diagnosis of dengue in the field or during medical consultations in
health care centers with minimal equipment. Moreover, an early
ICT for NS1 could be performed in parallel with an RDT for
malaria in tropical areas in which these two diseases are endemic.
The sensitivity of the pan-E Dengue Early ELISA was
significantly lower than that of the Platelia Dengue NS1 Ag test
or the Dengue NS1 Ag STRIP. This observation is consistent with
a previous study performed in Southeast Asia with fewer serum
samples (n=92), in which the pan-E Dengue Early ELISA had a
sensitivity of 63.2% (95% CI: 53.4% to 73.0%) for sera collected
between days four and seven after fever onset [19]. We also show
that this test differed significantly from the Platelia Dengue NS1
Ag and Dengue NS1 Ag STRIP tests for patients with the DENV-
4 serotype and with acute serum samples collected between days 0
and four. Thus, the pan-E Dengue Early ELISA should not be
used alone for acute diagnosis of DENV infection and should
instead be combined with MAC-ELISA, as suggested by Blacksell
et al. Furthermore, in practical terms, the Platelia Dengue NS1 Ag
test, which has a one-step sandwich-format (one incubation
period), is more convenient for technicians than the pan-E
Dengue Early ELISA test, which has two steps (two incubation
periods).
During the acute phase of the disease, the presence of DENV
IgM antibody alone suggests primary infection, and the concom-
itant detection of DENV IgM and IgG antibodies is suggestive of
secondary infection [18,20]. The absence of DENV IgG antibody
in serum samples collected between days 0 and eight makes it
possible to classify the case as primary DENV infection. It has also
been shown that, during the IgG antibody response, NS1-specific
IgG antibodies start to appear on day 8 of primary infection and
are still present during the first few days of DENV secondary
infection [21]. As suggested by Table 6, the sensitivity of NS1 Ag
detection with the three commercial tests would be expected to be
higher during primary infection than during secondary infection,
and we clearly showed greater sensitivity with the Platelia Dengue
NS1 Ag test or the Dengue NS1 Ag STRIP than with the pan-E
Dengue Early ELISA. This observation is consistent with recent
findings with the Platelia Dengue NS1 Ag assay [13]. During these
first few days of secondary infection, a substantial amount of NS1
protein may be bound to NS1-specific IgG antibodies from
previous acute-phase infection and trapped within immune
complexes [9,22]. This difference in the kinetics of NS1-specific
IgG antibodies between primary and secondary DENV infection is
certainly similar to the kinetics observed for total DENV IgG
antibodies. In addition, as observed in Table 3, the sensitivity of
NS1 detection rapidly decreases on day five of secondary DENV
infection, requiring NS1 detection between days 0 and four for an
accurate diagnosis.
The accurate laboratory diagnosis of DENV infection is now
possible with Dengue NS1 Ag detection tests, taking into account
the timing of serum collection after the onset of fever. Previous
studies have demonstrated a diagnostic strategy combining NS1
Ag detection in acute-phase sera and DENV IgM detection in
early-convalescent-phase sera, providing a sensitivity of about 90%
for dengue diagnosis [12,23]. The development of a single
immunochromatographic assay combining NS1 antigen and
DENV IgM antibody detection would provide clinicians with a
rapid test for dengue diagnosis sensitive during both the acute and
early convalescence phases, between days 0 and 8 after the onset of
fever.
NS1 detection has been shown to be suitable for early dengue
diagnosis, whatever the DENV serotype responsible for dengue
disease in Latin America and Southeast Asia, but only in two
retrospective studies [12,13]. Although these new diagnostic tools
have been designed using two monoclonal antibodies (Platelia and
ICT from Bio-Rad) or one monoclonal and one polyclonal
antibody (pan-E from Panbio) for NS1 capture, and given the
Figure 1. Sensitivity of the three tests for NS1 antigen detection, based on the presence or absence of IgG in the serum samples. A:
Serum samples with no IgG: Platelia Dengue NS1 Ag test (—e—), Dengue NS1 Ag STRIP 15 min (- - -%- - -) and 30 min (– –n– –), and pan-E Dengue
Early ELISA (– –+– –). B: Serum samples positive for IgG: Platelia Dengue NS1 Ag test (—X—), Dengue NS1 Ag STRIP 15 min (- - -&- - -) and 30 min, (–
–m– –) and pan-E Dengue Early ELISA (- - + - -).
doi:10.1371/journal.pntd.0000280.g001
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it would be interesting to evaluate these two new diagnostic tools
based on NS1 detection in prospective clinical studies in Asia and
Latin America. It would also be useful to evaluate the
performances of these kits taking into account different patient
profiles such as ethnicity or disease severity. However, the severe
fatal forms of the disease, such as DHF/DSS, are known to occur
between four and six days after fever onset, whereas NS1 detection
is optimized for all sera collected during the first five days of the
disease.
We show that the sensitivity of NS1 detection with the Dengue
NS1 Ag STRIP and Pan-E Dengue Early ELISA tests increased
from day 0 to day 3 after fever onset, with the largest effect
observed for serum samples without DENV IgG antibody. This
phenomenon may be correlated with an increase in NS1 secretion
over the first three days after fever onset [9]. This increase was not
detectable with the Platelia Dengue NS1 Ag test, possibly due to
the greater analytical sensitivity of the Platelia than of the Dengue
NS1 Ag STRIP and pan-E Dengue Early ELISA tests.
We observed an increase in the sensitivity of the Platelia Dengue
NS1 Ag and Dengue NS1 Ag STRIP tests on day 6 for serum
samples positive for DENV IgG antibody, probably correlated
with an increase in the amount of secreted NS1, but the number of
serum samples was small (n=15). Soluble NS1 protein binds to the
human endothelium in situ [11] and accumulates in hepatocytes
[25], possibly contributing to viral propagation. The release of
soluble NS1 protein from the endothelium or from hepatocytes
during DENV secondary infection may therefore play a role in the
pathophysiology of the disease. Alternatively, the persistence of
viral particles in capillary blood longer than in peripheral blood
promotes the late release of soluble NS1 protein [26]. Further
studies quantifying NS1 protein as a function of viral load in acute-
phase and early convalescence-phase sera will provide further
insight into these aspects.
In conclusion, this evaluation of two new commercial tests for
dengue diagnosis, Dengue NS1 Ag STRIP and pan-E Dengue
Early ELISA, and their comparison with the Platelia Dengue NS1
Ag test confirm that NS1 will be beneficial as a new marker in the
diagnosis of acute DENV infection. The first rapid immunochro-
matographic test, Dengue NS1 Ag STRIP, which performs well, is
suitable as a first-line test in the field, whereas pan-E Dengue Early
ELISA should be used with DENV IgM antibody detection for the
diagnosis of DENV infection.
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